Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients
Phase 1
Not yet recruiting
- Conditions
- Angiogenic Breast Cancer
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Advanced Imaging Projects, LLC
- Target Recruit Count
- 25
- Registration Number
- NCT04480619
- Locations
- 🇮🇳
Postgraduate Institute of Medical and Research, Chandigarh, India
🇮🇳All India Institute of Medical Sciences, New Delhi, India
🇿🇦University of Witwatersrand, Johannesburg, South Africa
A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.
Phase 1
Not yet recruiting
- Conditions
- Breast Cancer Stage IV
- Interventions
- Drug: Lutetium-177-DOTAGA-IAC
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Advanced Imaging Projects, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT04469127
- Locations
- 🇮🇳
Postgraduate Institute of Medical and Research, Chandigarh, India
🇿🇦CM Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
News
No news found